Results 31 to 40 of about 266,263 (247)

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Form as an Extension of Content

open access: yesInternational Journal of Digital Curation
In October 2020, a data archive for social sciences and digital humanities was launched at the Belgian national archives institution, the State Archives of Belgium.
Benjamin Peuch   +7 more
doaj   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Conferences

open access: yesArchives of Acoustics, 2013
Calendar of ...
Archives of Acoustics Archives of Acoustics
doaj  

„Tülitan teid oma Siberi keelega”. Rosalie Ottessoni mängukirjeldused Eesti Rahvaluule Arhiivis

open access: yesKeel ja Kirjandus, 2023
This article looks at the descriptions of games written down by Rosalie Ottesson, who lived in the Siberian Estonian community in Russia, mainly in the village of Ülem-Bulanka.
Anu Korb, Astrid Tuisk
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

15th International Symposium on Sound Engineering and Tonmeistering ISSET 2013

open access: yesArchives of Acoustics, 2013
The 15th International Symposium on Sound Engineering and Tonmeistering will be held on June 27–29 in Cracow. The Symposium is organised by the Department of Mechanics and Vibroacoustics, AGH University of Science and Technology, under the auspices of ...
Archives of Acoustics ARCHIVES OF ACOUSTICS
doaj  

Regional Office for Aid to the Victims of War in Prague (1919–1938)

open access: yesFaces of War
The killings and mutilations brought about by World War I left a significant mark on society: missing husbands and fathers, surviving war veterans, widows and orphans.
David Hubený, Nadezda Kruglova
doaj   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy